New implantable glucose monitor put to the test
NCT ID NCT07386340
Summary
This study is testing a new, long-term glucose monitoring system called Eversense Gemini for people with diabetes. It aims to see how accurately it measures blood sugar compared to standard fingerstick checks and an older version of the monitor. The study will also check the safety of the device, which is implanted under the skin and lasts for months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Headlands Research - AMCR Institute
RECRUITINGEscondido, California, 92025, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.